Erratum to “EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients” [Rev Iberoam Micol. 33 (4) (2016) 206–215]

In the article “EPICO 3.0. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients” (Rev Iberoam Micol. 2016;33(4):206–215), de P. Llinares et al., an error has been detected in the “Conflict of Interests” and “Acknowledgements” sections, being corrected:

Conflict of interests

This consensus has been sponsored by MSD Laboratories, Spain. MSD Spain only provided support to this research. MSD contributed neither to the scientific content nor to the final recommendations.

Acknowledgements

This research has the endorsement of the following Spanish Societies: the Spanish Society of Mycology (AEM), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Anesthesiology, Reanimation and Pain Therapeutics (SEDAR), the Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Chemotherapy (SEQ), and the Spanish Society of Hospital Pharmacies (SEFH). We thank Carmen Romero and Ainhoa Torres (Entheos Editorial Group) for their excellent work and dedication to this project.